Interestingly, we observed a tendency of increase in macrophage numbers in mice with NASH treated with IL-1β blocker, while Ccl2 gene expression was slightly diminished by the treatment. This evidence concerns the gene IL1B and metabolic dysfunction-associated steatohepatitis.